Akari Therapeutics plc ADS - ADR Financials

$10.88

$0.31 (2.93%)

As on 10-Sep-2026 16:00EDT

Market cap

$22 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	0.01	0.00	0.00	0.00
Gross Profit	--	--	-0.01	0.00	0.00	0.00
Operating Expenses	30.99	17.28	21.64	16.81	23.09	17.21
Operating Profit (EBIT)	-30.99	-17.28	-21.64	-16.81	-23.09	-17.21
Other Income	--	--	--	--	--	--
Profit before Tax	-32.82	-18.30	-19.79	-10.01	-17.75	-17.42
Provision for Tax	-1.86	-1.00	--	--	-10.78	0.18
Profit after Tax (Net Income)	-30.96	-17.30	-19.79	-10.01	-17.75	-17.42
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-17.42

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	18.60	28.33	22.23	-0.23	1.79	5.55
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	6.09	7.21	8.42	--	0.95	4.30
Current Liabilities	13.94	12.35	19.91	4.58	12.04	6.09
Total Liabilities	52.56	47.89	50.56	4.36	13.83	11.65

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	30.30	42.43	47.61	0.01	0.02	0.02
Current Assets	8.32	5.46	2.95	4.34	13.82	11.63
Total Assets	52.56	47.89	50.56	4.36	13.83	11.65
Total Debt*	0.69	0.75	3.26	--	--	--
Net Current Assets	-5.61	-6.89	-16.96	-0.24	1.77	5.53

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-10.57	-12.55	-16.43	-21.50	-18.85
Cash Flow from Investing Activities	--	--	0.38	--	--	--
Cash from Financing Activities	--	13.17	10.99	7.02	25.29	14.29
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1,335.94	-823.71	0.00	-4,549.09	-10,440.00	-14,520.20
Cash EPS ($)	--	-823.71	0.00	-4,547.27	-10,437.82	-14,516.76
Adjusted Book Value ($)	--	1,348.95	0.00	--	1,053.53	4,628.82
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-503.24	0.00	-7,469.09	-12,649.41	-15,705.44
Free Cash Flow per Share ($)	--	-503.24	0.00	-7,469.09	-12,649.41	-15,705.44

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-63.40	-156.70	-1,281.43	-483.23	-233.27
ROE (%)	-131.96	-68.43	-179.92	-1,281.43	-483.23	-233.27
ROA (%)	-51.34	-35.14	-72.08	-110.06	-139.31	-132.74
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	--	--	-95.31	43.61	-1.86	3.10
Net Profit Growth (%)	-152.38	12.60	-97.75	43.61	-1.86	-2.01
EPS Growth (%)	-53.96	-2,214,284.72	1.00	0.56	0.28	0.40
Book Value Growth (%)	-99.36	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	0.00	-3,278.66	0.00	0.00	0.00
Price / Book Value	1.05	0.00	2,919.07	-0.03	0.00	0.00
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.06	0.26	-3,322.00	0.38	0.75	0.54
Close Price ($)	10.25	11.56	48.80	124.80	375.92	1,200.00
High Price ($)	49.60	69.20	176.00	439.92	1,288.00	3,368.00
Low Price ($)	3.02	8.71	36.00	109.20	304.80	1,056.00
Market Cap ($ Cr)	22.33	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.03	0.15	--	--	--
Short term debt to equity ratio	0.04	0.03	0.15	--	--	--
Current Ratio	0.60	0.44	0.15	0.95	1.15	1.91
Quick Ratio	0.60	--	--	--	1.35	--
Interest Coverage	-32.35	--	-80.11	--	-3.32	-82.93

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	-226,980.59	-244,855.01	-46,198.90
Payable days	--	--	183,655.60	119,528.06	134,730.90	228,805.53
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.